Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J-P Bru

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
Revue Medicale Suisse|June 6, 2012
[Forgotten hepatitis: the hepatitis E]J-P Bru
Medecine Et Maladies Infectieuses|May 1, 2012
Role of intravenous cloxacillin for inpatient infectionsJ P Bru, R Garraffo
Presse Medicale (Paris, France : 1983)|June 30, 2000
[Treatment of community-acquired pneumonia with levofloxacin: 500 mg once a day or 500 mg twice a day?]P Zuck, J P Bru
Medecine Et Maladies Infectieuses|January 29, 2005
[Bacterial resistance and therapeutic failure]J-P Bru, C Carbon, P Leophonte
Medecine Et Maladies Infectieuses|October 26, 2005
[Link between resistance and failure in community-acquired respiratory infections]J P Bru, P Léophonte, C Carbon
Revue De Pneumologie Clinique|January 28, 2004
[Levofloxacine for the treatment of pneumococcal pneumonia: results of a meta-analysis]J-P Bru, P Leophonte, P Veyssier
Medecine Et Maladies Infectieuses|December 25, 2004
[Management of communal lower respiratory tract infections in the emergency ward: the role of Ketek (telithromycine)]L Dubreuil, D Elkharrat, J P Bru
Medecine Et Maladies Infectieuses|November 1, 2005
J-P Bru, P Léophonte, C Carbon
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 1, 1994
Penicillin G/ofloxacin versus erythromycin/amoxicillin-clavulanate in the treatment of severe community-acquired pneumoniaJ Gaillat, J P Bru, A Sedallian
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 10, 2022
'Treatment of Coxiella burnetii endocarditis with hydroxychloroquine' - Author's replyJ P Stahl, E Varon, J P Bru
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Revue Medicale Suisse|June 6, 2012
[Forgotten hepatitis: the hepatitis E]J-P Bru
Medecine Et Maladies Infectieuses|May 1, 2012
Role of intravenous cloxacillin for inpatient infectionsJ P Bru, R Garraffo
Presse Medicale (Paris, France : 1983)|June 30, 2000
[Treatment of community-acquired pneumonia with levofloxacin: 500 mg once a day or 500 mg twice a day?]P Zuck, J P Bru
Medecine Et Maladies Infectieuses|January 29, 2005
[Bacterial resistance and therapeutic failure]J-P Bru, C Carbon, P Leophonte
Medecine Et Maladies Infectieuses|October 26, 2005
[Link between resistance and failure in community-acquired respiratory infections]J P Bru, P Léophonte, C Carbon
Revue De Pneumologie Clinique|January 28, 2004
[Levofloxacine for the treatment of pneumococcal pneumonia: results of a meta-analysis]J-P Bru, P Leophonte, P Veyssier
Medecine Et Maladies Infectieuses|December 25, 2004
[Management of communal lower respiratory tract infections in the emergency ward: the role of Ketek (telithromycine)]L Dubreuil, D Elkharrat, J P Bru
Medecine Et Maladies Infectieuses|November 1, 2005
J-P Bru, P Léophonte, C Carbon
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 1, 1994
Penicillin G/ofloxacin versus erythromycin/amoxicillin-clavulanate in the treatment of severe community-acquired pneumoniaJ Gaillat, J P Bru, A Sedallian
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 10, 2022
'Treatment of Coxiella burnetii endocarditis with hydroxychloroquine' - Author's replyJ P Stahl, E Varon, J P Bru
Pageof 6